NEWS & EVENTS
Featured
Cytek® Biosciences Introduces New 20-Color AML Panel
Cytek Biosciences, Inc. (Nasdaq: CTKB), a leading cell analysis solutions company, today announced the launch of a new 20-Color Acute Myeloid Leukemia (AML) Panel.
Sale of Flow Cytometry and Imaging Business from DiaSorin to Cytek® Biosciences Completed
DiaSorin (FTSE MIB: DIA) and Cytek Biosciences, Inc. (Nasdaq: CTKB) today announced that Luminex Corporation, a wholly owned
Cytek® Biosciences to Acquire Flow Cytometry and Imaging Business from DiaSorin
DiaSorin and Cytek Biosciences, Inc. today announced that Luminex Corporation, a wholly owned subsidiary
Cytek® Biosciences Partners with Bio-Rad to Expand Reagent Portfolios
Delivering a boost to immuno-oncology and immunotherapy researchers, Cytek Biosciences, Inc. today announced that it has entered into a strategic partnership